Stable nitric oxide releasing compound that is orally absorbed in rats.
Product Details
| Alternative Name: | 1,2,3,4-Oxatriazolium, 3-(3-chloro-2-methylphenyl)-5-(((cyanomethylamino)carbonyl)amino)-, hydroxide inner salt |
| |
| Formula: | C11H9ClN6O2 |
| |
| MW: | 292.7 |
| |
| Purity: | ≥97% (HPLC) |
| |
| Identity: | Determined by IR. |
| |
| Appearance: | White to off-white crystalline solid. |
| |
| Solubility: | Soluble in DMSO. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | +4°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Cytokine- or chemically derived nitric oxide alters the expression of proteins detected by two-dimensional gel electrophoresis in neonatal rat islets of Langerhans: N.E. John, et al.; Diabetes
49, 1819 (2000),
Abstract;
Mesoionic oxatriazole derivatives--a new group of NO-donors: G. Karup, et al.; Pol. J. Pharmacol.
46, 541 (1994),
Abstract;
Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems: T. Corell, et al.; Pol. J. Pharmacol.
46, 553 (1994),
Abstract;
Scavenging of superoxide anions by nitric oxide donors: J. Robak, et al.; Pharmacol. Res. 25 S2, 355 (1992),
